Comorbidity in psychology refers to the presence of two or more mental health disorders in the same person at the same time. Someone diagnosed with depression who also meets the criteria for generalized anxiety disorder, for example, has comorbid conditions. The term originally comes from general medicine, where it was introduced in 1970 to describe any distinct additional disease occurring alongside a primary diagnosis. Psychiatry adopted the concept in the 1980s and has been wrestling with its implications ever since.
Why Comorbidity Works Differently in Mental Health
In physical medicine, comorbidity is relatively straightforward. A patient with diabetes who also has heart disease has two conditions with known biological causes and distinct tissue damage that can be measured and observed. The original definition required that each comorbid condition be a “distinct additional clinical entity” with either a known cause or identifiable pathology in the body.
Mental health disorders rarely meet that standard. Most psychiatric conditions have no single known cause and no biomarker a clinician can point to on a scan or blood test. Diagnoses are based on clusters of symptoms, and those symptom clusters overlap significantly. Trouble sleeping, difficulty concentrating, and irritability appear in depression, anxiety, PTSD, and ADHD. This raises a genuinely difficult question: when someone has symptoms of both depression and anxiety, are they experiencing two separate disorders, or one underlying condition that produces both sets of symptoms? The honest answer is that clinicians often can’t be sure.
In traditional medicine, the principle is to prefer a single diagnosis if it can account for all the patient’s symptoms. Psychiatry frequently does the opposite, assigning multiple diagnoses when symptoms span more than one category in the diagnostic manual. This isn’t necessarily wrong, but it means psychiatric comorbidity is a fundamentally different kind of claim than medical comorbidity.
How Common It Is
Comorbidity in mental health is not the exception. It’s closer to the rule. More than one in four adults living with serious mental health problems also has a substance use problem, according to SAMHSA. Depression and anxiety co-occur so frequently that some researchers question whether they should be classified as separate conditions at all. Among adolescents with substance use disorders, rates of co-occurring mood disorders, anxiety, conduct disorder, and ADHD are especially high.
Other common pairings include PTSD with substance use, chronic pain with depression, and psychotic disorders with personality disorders. The pattern holds across age groups and populations: once a person meets criteria for one mental health condition, the probability of meeting criteria for a second rises sharply.
The Most Common Pairings
Some combinations show up far more often than chance would predict:
- Depression and anxiety: These two co-occur so regularly that many clinicians treat them as a package rather than separate problems.
- Substance use and mood disorders: Depression, anxiety, schizophrenia, and personality disorders all occur more frequently alongside substance use problems.
- PTSD and substance use: People with trauma histories often develop substance use problems, and vice versa.
- Chronic pain and depression: Physical pain and depressed mood share overlapping brain circuits, and each condition worsens the other.
- ADHD and conduct disorder: Particularly common in adolescents, where impulsivity and behavioral problems frequently overlap.
Why Disorders Cluster Together
There are several reasons mental health conditions tend to travel in groups, and they aren’t mutually exclusive.
Shared Genetics
A major 2025 study published in Nature mapped the genetic landscape across 14 psychiatric disorders and found that about two-thirds of the genetic variation in individual disorders could be explained by just five underlying genetic factors shared across conditions. Schizophrenia and bipolar disorder, for instance, share the majority of their genetic signal. Depression, PTSD, and anxiety cluster together on a separate genetic factor. A gene cluster on chromosome 11, known as a “pleiotropy hotspot,” has been linked to intelligence, personality, substance use, and sleep, illustrating how a single stretch of DNA can influence vulnerability to multiple conditions at once.
This shared genetic architecture helps explain why finding a biological cause unique to one specific disorder has been so difficult. The genetic risk factors for mental illness are largely transdiagnostic, meaning they cut across diagnostic categories rather than mapping neatly onto them.
Shared Brain Mechanisms
Different disorder clusters appear to involve different types of brain cells. The genetic factor linking schizophrenia and bipolar disorder was enriched in excitatory neurons (cells that activate brain circuits), while the factor linking depression, PTSD, and anxiety was associated with oligodendrocytes (cells that insulate nerve fibers and help them communicate efficiently). These findings suggest that comorbid conditions may share not just symptoms but actual biological pathways.
One Condition Causing Another
Sometimes the relationship is more sequential. Chronic anxiety can erode sleep, social functioning, and self-worth to the point where depression develops. Substance use that begins as self-medication for PTSD can progress into a full substance use disorder. In these cases, comorbidity reflects a cascade rather than a shared root cause.
The P-Factor: A General Vulnerability
One influential theory proposes that all mental health disorders share a single underlying dimension of risk, called the p-factor. The concept parallels the g-factor in intelligence research: just as g represents a general mental ability that influences performance across cognitive tasks, p represents a general tendency toward psychopathology that influences vulnerability across diagnostic categories.
People who score higher on this dimension tend to experience more severe symptoms, longer episodes, greater impairment in daily life, more comorbid diagnoses over their lifetime, and more evidence of altered brain function from childhood onward. They also tend to have stronger family histories of mental illness. The p-factor doesn’t replace individual diagnoses, but it offers an explanation for why comorbidity is so pervasive. If there’s a general liability toward mental health problems, then having one disorder is a signal that the underlying vulnerability is elevated, making additional disorders more likely.
This framework also explains a longstanding frustration in psychiatric research: treatments, biomarkers, and risk factors that seem promising for one disorder almost always turn out to be relevant to several others. That’s exactly what you’d expect if the conditions share a common core.
Why Comorbidity Makes Diagnosis Harder
When a person has multiple conditions, each one can obscure the others. This problem has a name: diagnostic overshadowing. It occurs when symptoms of one illness are mistakenly attributed to an already-diagnosed condition, causing the second condition to go unrecognized and untreated.
The most well-documented version involves physical symptoms being dismissed as part of a mental health diagnosis. A person with schizophrenia who reports chest pain may have that pain written off as anxiety or psychosomatic, when it could indicate a cardiac problem. But overshadowing also works in the other direction. Someone with a long history of chronic pain may develop depression that gets overlooked because their low mood is seen as a natural response to pain rather than a separate treatable condition.
There’s also the problem of symptom overlap. Many of the criteria for depression (fatigue, poor concentration, sleep disturbance) also appear in anxiety disorders, PTSD, and ADHD. A clinician has to determine whether those symptoms belong to one diagnosis or multiple, and that judgment call can vary significantly depending on the clinician’s training, the order in which symptoms are assessed, and which condition is considered first.
How Comorbidity Affects Treatment and Recovery
Comorbid conditions are harder to treat, take longer to resolve, and carry higher rates of relapse. Research on patients with both mental health and cardiovascular conditions found that having comorbid conditions increased the risk of hospital readmission by roughly 53%. The pattern holds broadly: more diagnoses generally means more healthcare visits, higher costs, and a longer road to stability.
Traditionally, each disorder received its own treatment protocol. Someone with both panic disorder and depression might be given one type of therapy for panic and a different one for depression, sometimes by different providers. This approach is time-consuming, expensive, and often impractical.
A newer approach called transdiagnostic treatment targets the shared mechanisms that drive multiple disorders rather than addressing each diagnosis separately. The Unified Protocol, for example, is a form of cognitive behavioral therapy designed to address the emotional patterns common to anxiety, depression, and related conditions. Rather than treating avoidance of panic sensations and avoidance of sad thoughts as separate problems, it treats the tendency to avoid intense emotions as the shared problem driving both. Studies have shown that this single protocol produces lasting results comparable to disorder-specific treatments, while being more efficient for both patients and providers.
This shift toward transdiagnostic treatment reflects a broader recognition in the field: if mental health conditions share underlying causes, treating those shared causes directly may be more effective than chasing each diagnosis individually.